all news

Thu, 29 Oct 2026 PR Newswire

Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade

Wed, 28 Oct 2026 Harvard Pilgrim Health Care

Harvard Pilgrim adds well-being solutions to its suite of products

Fri, 23 Oct 2026 Business Wire

TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Po

Wed, 21 Oct 2026 PR Newswire

Muna Therapeutics Announces Positive Phase 1 Results Supporting Potential of Oral Small-Molecule TREM2 Modulator, MNA-001, in Alzheimer's Disease

Tue, 20 Oct 2026 Yahoo! Finance

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option

Thu, 15 Oct 2026 GlobeNewswire

Proof launches x401, giving AI agents a way to prove who they represent—and what they're authorized to do

Tue, 13 Oct 2026 Alector (United States)

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Othe

Tue, 13 Oct 2026 Business Wire

Soufflé Therapeutics™ Announces Oversubscribed $135 Million Series B Financing to Advance Lead Clinical Programs and Continued Pipeline Prog

Tue, 13 Oct 2026 GlobeNewswire

Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Sun, 11 Oct 2026 GlobeNewswire

Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026

Sun, 11 Oct 2026 GlobeNewswire

Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure

Thu, 8 Oct 2026 GlobeNewswire

TRexBio Announces Pricing of Initial Public Offering

Mon, 5 Oct 2026 BioSpace

Dyno Therapeutics Presents New Multi-Mechanism Muscle Capsid Data at the 31st International Congress of the World Muscle Society

Thu, 1 Oct 2026 Business Wire

TriGemX Bio Announces $94M Financing and Initiation of Phase 3 Trials for Elismetrep, A Potential First-in-Class Treatment for Migraine

Tue, 29 Sep 2026 Markets Insider - Business Insider

Tectonic Therapeutic announces results from Phase 1a trial of TX2100

Thu, 24 Sep 2026 Yahoo! Finance

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

Mon, 14 Sep 2026 GlobeNewswire

Wellthy Acquires Cleo as Two Leaders Come Together to Create the Singular Platform for Family Care

Mon, 14 Sep 2026 PR Newswire

FDA Approves ISEMBYLD™ for People Living with SMA

Tue, 11 Aug 2026 Associated Press

Cohere Health Ranks 390 on the 2026 Inc. 5000 List of Fastest-Growing Private Companies, Marking Second Consecutive Year

Tue, 11 Aug 2026 Yahoo! Finance

FloQast Recognized by Inc. as One of America's Fastest Growing Private Companies for Fourth Consecutive Year

Tue, 4 Aug 2026 GlobeNewswire

Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing

Tue, 4 Aug 2026 Business Wire

Satellite Bio Announces FDA Clearance of IND Application for SB-101 for the Treatment of Urea Cycle Disorders (UCDs) Marking its Transition to a Clinical-Stage Biotechnology Company

Tue, 4 Aug 2026 Benzinga

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Mon, 20 Jul 2026 Yahoo! Finance

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Tue, 14 Jul 2026 Yahoo! Finance

Hummingbird Bioscience Wins APAC Trailblazer Award at 2026 Nebius AI Discovery Awards

Thu, 9 Jul 2026 PR Newswire

Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints

Tue, 30 Jun 2026 Yahoo! Finance

TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051

Wed, 10 Jun 2026 GlobeNewswire

Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients

Tue, 2 Jun 2026 Yahoo! Finance

Tavo Biotherapeutics Announces $17 Million Series A Financing to Advance Novel Therapies in Glaucoma and Retinal Disease

Thu, 21 May 2026 Business Wire

Arsenal Medical Receives FDA IDE Approval for the RADIANT Pivotal Trial of NeoCast™ in Chronic Subdural Hematoma